Phreesia Management
Management criteria checks 3/4
Phreesia's CEO is Chaim Indig, appointed in Jan 2005, has a tenure of 19.33 years. total yearly compensation is $7.60M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 2.3% of the company’s shares, worth $27.29M. The average tenure of the management team and the board of directors is 3.3 years and 16.6 years respectively.
Key information
Chaim Indig
Chief executive officer
US$7.6m
Total compensation
| CEO salary percentage | 6.8% |
| CEO tenure | 19.3yrs |
| CEO ownership | 2.3% |
| Management average tenure | 3.3yrs |
| Board average tenure | 16.6yrs |
Recent management updates
Recent updates
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12
Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Phreesia Q3 2023 Earnings Preview
Dec 07Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M
Sep 07Phreesia: Their Time Has Passed
May 10Opportunistic Time To Buy Phreesia's Healthcare Disruption
Dec 27Are Phreesia, Inc. (NYSE:PHR) Investors Paying Above The Intrinsic Value?
Nov 08Is It Time To Consider Buying Phreesia, Inc. (NYSE:PHR)?
Sep 15Phreesia (PHR) Investor Presentation - Slideshow
Jun 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jan 31 2024 | n/a | n/a | -US$137m |
| Oct 31 2023 | n/a | n/a | -US$144m |
| Jul 31 2023 | n/a | n/a | -US$152m |
| Apr 30 2023 | n/a | n/a | -US$162m |
| Jan 31 2023 | US$8m | US$515k | -US$176m |
| Oct 31 2022 | n/a | n/a | -US$185m |
| Jul 31 2022 | n/a | n/a | -US$181m |
| Apr 30 2022 | n/a | n/a | -US$158m |
| Jan 31 2022 | US$9m | US$515k | -US$118m |
| Oct 31 2021 | n/a | n/a | -US$80m |
| Jul 31 2021 | n/a | n/a | -US$50m |
| Apr 30 2021 | n/a | n/a | -US$32m |
| Jan 31 2021 | US$6m | US$419k | -US$27m |
| Oct 31 2020 | n/a | n/a | -US$23m |
| Jul 31 2020 | n/a | n/a | -US$19m |
| Apr 30 2020 | n/a | n/a | -US$83m |
| Jan 31 2020 | US$10m | US$346k | -US$91m |
| Oct 31 2019 | n/a | n/a | -US$102m |
| Jul 31 2019 | n/a | n/a | -US$113m |
| Apr 30 2019 | n/a | n/a | -US$54m |
| Jan 31 2019 | US$510k | US$300k | -US$45m |
Compensation vs Market: Chaim's total compensation ($USD7.60M) is above average for companies of similar size in the US market ($USD3.42M).
Compensation vs Earnings: Chaim's compensation has been consistent with company performance over the past year.
CEO
Chaim Indig (44 yo)
19.3yrs
Tenure
US$7,604,450
Compensation
Mr. Chaim Indig co-founded Phreesia, Inc. in January 2005 and serves as Chief Executive Officer and Director since January 2005. Mr. Indig has helped to revolutionize the patient check-in experience. Under...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 19.3yrs | US$7.60m | 2.3% $ 27.3m | |
| Co-Founder & COO | 19.3yrs | US$3.95m | 1.34% $ 15.9m | |
| Senior Vice President of Life Sciences | 5.2yrs | US$3.92m | 0.37% $ 4.4m | |
| Chief Financial Officer | 1.2yrs | no data | 0.17% $ 2.0m | |
| VP, Principal Accounting Officer & Controller | 1.1yrs | no data | 0.062% $ 740.0k | |
| Chief Technology Officer | less than a year | no data | no data | |
| General Counsel & Secretary | 3.8yrs | US$3.05m | 0.056% $ 669.2k | |
| Vice President of Corporate Communications | 3.3yrs | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Senior Vice President of Human Resources | 14.1yrs | no data | 0.21% $ 2.5m | |
| Chief Clinical Officer | 3.1yrs | no data | no data | |
| Chief Privacy Officer | less than a year | no data | no data |
3.3yrs
Average Tenure
49yo
Average Age
Experienced Management: PHR's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 19.3yrs | US$7.60m | 2.3% $ 27.3m | |
| Board Observer | no data | no data | no data | |
| Independent Director | 16.6yrs | US$228.70k | 0.063% $ 750.3k | |
| Independent Chairman | 19.3yrs | US$385.00k | 0.31% $ 3.7m | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 5yrs | US$252.45k | 0.018% $ 214.7k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 5.6yrs | US$241.25k | 0.011% $ 128.4k |
16.6yrs
Average Tenure
61yo
Average Age
Experienced Board: PHR's board of directors are seasoned and experienced ( 16.6 years average tenure).